Jason Springs is currently the CEO of GeneWeave Biosciences, LLC. His company develops diagnostic devices that detect the presence and drug-resistance of disease-causing bacteria without the need for a diagnostic laboratory. The company is particularly focused on detecting so-called "superbugs" -disease-causing bacteria that are resistant or immune to standard antibiotics, as well as bacteria responsible for many hospital-acquired infections (HAIs).
Jason Springs is a first year MBA student at the Johnson School at Cornell University. He received his undergraduate degree in Economics and Management from the University of South Carolina.
Sure, so what we are is a molecular diagnostics company and that's a fancy word for saying we find if you're sick or not. What we have is a very simply point of care diagnostic to detect bacteria and to determine whether bacteria are drug resistant or not. The bacteria that we're concerned about a...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login